Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D

NCT05856877 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Central Insulin Resistance
Diabetes Mellitus, Type 2
PreDiabetes

Interventions

OTHER: Human nasal insulin
OTHER: Placebo

Sponsor

University Hospital Tuebingen